US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

  • Biopharmaceuticals (194)
  • Diseases & Conditions (3448)
  • Drug Delivery (184)
  • Therapeutic Area (5590)
  • Vaccines (631)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Chemical & Pharmaceutical Plant Construction in the Philippines to 2018: Market Databook
10/23/2014 | published by: Timetric
... for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry ...  |  read more...
USD 500
Iraq Pharmaceuticals and Healthcare Report Q4 2014
10/22/2014 | published by: Business Monitor International
... toinvest USD12bn into healthcare expansions in 2014, and the Ministry of Health recently awarded 18 healthproject contracts worth USD276mn. However, the projected growth of Iraq's pharmaceutical market in 2014and 2015 is linked to an oil-driven ...  |  read more...
USD 1,295
Lithuania Pharmaceuticals and Healthcare Report Q4 2014
10/22/2014 | published by: Business Monitor International
... are singularly small, togetherthey represent an attractive and modest-sized market. The Lithuanian market on its own will pose a modestopportunity for drugmakers due to its small absolute size relative to its neighbouring markets. We expectthe ...  |  read more...
USD 1,295
Portugal Pharmaceuticals and Healthcare Report Q4 2014
10/22/2014 | published by: Business Monitor International
... agreements between the Portuguese government and the pharmaceutical industryto reduce public spending on medicines and on expected incentives for pharmacies to increase the use ofgenerics. Meanwhile, rapid growth in the Portuguese private healthcare sector suggests ...  |  read more...
USD 1,295
Physician Views: Can Portola's reversal agent act as growth catalyst for novel anticoagulants?
10/8/2014 | published by: FirstWord
... patients who have received therapy with a Factor Xa inhibitor, but whom subsequently need the anticoagulant action to be reversed due to bleeding or the requirement for surgery. Portola's assertion that andexanet alfa will meet ...  |  read more...
USD 645
Malignant Melanoma: KOL Insight
10/17/2014 | published by: FirstWord
... would prescribe them, and the factors likely to affect their future positioning and competitiveness. The recent US approval of Merck's PD-1 inhibitor Keytruda (pembrolizumab) and the expected approval of BMS' Opdivo (nivolumab) are ushering in ...  |  read more...
USD 6,495
Retinopathy Of Prematurity - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
... information on the therapeutic development for Retinopathy Of Prematurity, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Nerve Gas & Pestiside Poisioning - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Nerve Gas & Pestiside Poisioning, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Premature Labor (Tocolysis) - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
... information on the therapeutic development for Premature Labor (Tocolysis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Plunkett's Biotech & Genetics Industry Almanac 2015: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies
10/25/2014 | published by: Plunkett Research, Ltd.
... trends analysis, market data and competitive intelligence Market forecasts and Industry Statistics Industry Associations and Professional Societies List In-Depth Profiles of hundreds of leading companies Industry Glossary Buyer may register for free access to search ...  |  read more...
USD 349.99
Pfizer Inc (PFE: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/27/2014 | published by: Plunkett Research, Ltd.
... its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (Pfizer Inc) includes growth forecast for its primary industry to the year 2021. The purpose of this ...  |  read more...
USD 1,795
Gonorrhea - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
... Gonorrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Hand, Foot And Mouth Disease - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hand, Foot And Mouth Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Proliferative Diabetic Retinopathy (PDR), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
... I) (Hurler Syndrome)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Mucopolysaccharidosis I (MPS I) (Hurler Syndrome), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of ...  |  read more...
USD 2,000
Mycosis Fungoides - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
... therapeutic development for Mycosis Fungoides, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Pharmaceuticals and Healthcare Report - Pakistan Q4 2014
10/8/2014 | published by: Business Monitor International
... suffer from inadequateaccess to medicines and healthcare provision. However, Pakistan's drug registration process has beenplagued by delays, affecting the population's access to drugs and limiting revenue-earning opportunities fordrugmakers. In addition to this and further obstructing ...  |  read more...
USD 1,295
Clinical Trails Market in India - 2014
10/13/2014 | published by: Feedback Business Consulting Services Pvt. Ltd.
... in India for FY14 Share of Clinical Trials Registered in Asia No. of Trials Registered in India Distribution of Trials on basis of Phase Trials on basis of Therapeutic Areas Providing insights into Industry drivers ...  |  read more...
USD 4,000
Neonatal Ventilator Market in India - 2014
10/13/2014 | published by: Feedback Business Consulting Services Pvt. Ltd.
... in India for FY14 Geographical presence of key players in India Providing insights into Industry drivers and challenges and their impact on the future market Regulatory bodies and their roles Future Market projections for 5 ...  |  read more...
USD 1,500
Germ Cell Tumors - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
... information on the therapeutic development for Germ Cell Tumors, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
... information on the therapeutic development for Hormone-Sensitive Prostate Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Medical Packaging Industry in India - 2014
10/13/2014 | published by: Feedback Business Consulting Services Pvt. Ltd.
... in India for FY14 Geographical presence of key players in India Providing insights into Industry drivers and challenges and their impact on the future market Regulatory bodies and their roles Future Market projections for 5 ...  |  read more...
USD 1,000
Conference Documentation: European Pharmaceutical Pricing and Reimbursement
10/13/2014 | published by: SMI Publishing, Ltd
... oldest market leaders in the pharmaceutical industries calendar for some time. Our expert speaking faculty; made up from key industry personnel from big pharma, biotech and academia will thoroughly explain and offer advice on P&R ...  |  read more...
USD 788.78
Kidney Dialysis Centers
10/13/2014 | published by: First Research, Inc.
... Braun Melsungen. The global dialysis services market generates annual revenue of about $60 billion, according to Fresenius. Some 2.5 million people worldwide receive dialysis treatment. Demand for kidney dialysis services is growing in emerging economies ...  |  read more...
USD 129
Medicinal and Botanical Manufacturing Industry in the U.S. and its International Trade [2014 Q4 Edition]
10/20/2014 | published by: Supplier Relations US, LLC
... data, cost and pricing, competitive landscape, industry structure. Also updated are the latest trade, shipment, and inventory data available through October 2014. This update provides the data necessary to make informed forecasts and business planning ...  |  read more...
USD 599
< prev 1    3  4  5  6  7  8  9  10